Researchers from Massachusetts General Hospital and Harvard Medical School have developed a microfluidic device that can be used as an alternative to flow cytometry for measuring T cell counts in people infected with HIV. They hope that the small handheld device will help Africans — it will first be tested in Rwanda — in poor regions to better manage their disease.